Compare PSQH & IXHL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PSQH | IXHL |
|---|---|---|
| Founded | 2021 | 2001 |
| Country | United States | Australia |
| Employees | N/A | N/A |
| Industry | Advertising | |
| Sector | Consumer Discretionary | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 60.1M | 49.1M |
| IPO Year | N/A | N/A |
| Metric | PSQH | IXHL |
|---|---|---|
| Price | $1.46 | $0.46 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $6.00 | N/A |
| AVG Volume (30 Days) | 650.5K | ★ 23.6M |
| Earning Date | 11-06-2025 | 11-14-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $27,534,522.00 | $12,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $48.49 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 196.08 | N/A |
| 52 Week Low | $1.23 | $0.08 |
| 52 Week High | $5.58 | $2.25 |
| Indicator | PSQH | IXHL |
|---|---|---|
| Relative Strength Index (RSI) | 42.86 | 64.33 |
| Support Level | $1.25 | $0.35 |
| Resistance Level | $1.35 | $0.50 |
| Average True Range (ATR) | 0.11 | 0.03 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 63.89 | 80.58 |
PSQ Holdings Inc operates the website and mobile application named as PublicSq. It is an app and website that connects freedom-loving Americans to high-quality businesses that share values, both online and in local communities. It has three reportable segments comprised of Marketplace; which includes a marketplace platform to access consumers that are drawn to patriotic values and the revenue is generated in the form of advertising and eCommerce transactions, and Brands segment in which through its wholly-owned brand, the company generates revenue from online sales of diapers and wipes and third financial technology which assists consumers, lenders, and retailers in offering point-of-sale financing products.
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.